Paricalcitol — CAS 137000-91-6

Paricalcitol is a synthetic vitamin D analog used in the prevention and treatment of secondary hyperparathyroidism associated with chronic kidney disease (CKD). It selectively activates the vitamin D receptor (VDR) in the parathyroid glands and reduces PTH levels. Mediocon Inc manufactures this API at its GMP-certified facility in Aurangabad, Maharashtra, India.

• Prevention and treatment of secondary hyperparathyroidism in CKD patients
• Management of elevated PTH levels in dialysis patients
• Renal osteodystrophy treatment and bone disease prevention
• Selective vitamin D receptor activation with reduced hypercalcemic effects

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support